Related Experiment Video
Updated: Feb 16, 2026

In Vivo Imaging of Transduction Efficiencies of Cardiac Targeting Peptide
Published on: June 11, 2020
Pacifastin-derived Peptides Target Tumors for Use in In Vivo Imaging
Theo L Sottero1,2, Emily J Girard1, Carrie Myers1
1Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, U.S.A.
Background/Aim:
Developments in imaging have improved cancer diagnosis, but identification of malignant cells during surgical resection remains a challenge. The aim of this study was to investigate the pacifastin family of peptides for novel activity targeting tumor cells and the delivery of either imaging or therapeutic agents.
Materials And Methods:
Variants of pacifastin family peptides were generated, chemically modified and tested in human tumor xenografts.
Results:
A tumor-homing peptide-dye conjugate (THP1) accumulated in tumors in vivo and was internalized into cells. Examination of related peptides revealed residues critical for accumulation and allowed the engineering of improved tumor-targeting variants. A THP1-drug conjugate carrying the microtubule inhibitor, MMAE, showed limited activity in vitro and no difference compared to vehicle control in vivo.
Conclusion:
Although there are some obstacles to developing pacifastin-derived peptides for therapeutic activity, these optimized peptides have great promise for cancer imaging.
Insights
Researchers explored pacifastin peptides for cancer imaging and therapy. Optimized tumor-homing peptides show promise for cancer imaging, though therapeutic applications face challenges.
Area of Science:
- Oncology
- Peptide Chemistry
- Bioconjugation
Background:
- Cancer diagnosis relies on imaging, but precise identification of malignant cells during surgery is difficult.
- The pacifastin family of peptides presents a potential avenue for targeting tumor cells.
- Investigating these peptides could lead to new methods for delivering imaging or therapeutic agents to tumors.
Purpose of the Study:
- To explore the pacifastin family of peptides for novel activities targeting tumor cells.
- To assess their potential for delivering imaging or therapeutic agents.
- To engineer improved tumor-targeting variants.
Main Methods:
- Generation and chemical modification of pacifastin family peptide variants.
- In vivo testing of peptide-dye conjugates in human tumor xenografts.
- Evaluation of peptide-drug conjugates for in vitro and in vivo activity.
Main Results:
- A tumor-homing peptide-dye conjugate (THP1) demonstrated accumulation and cellular internalization in tumors.
- Key residues for tumor accumulation were identified, enabling the engineering of enhanced variants.
- A THP1-drug conjugate showed limited in vitro efficacy and no significant in vivo therapeutic effect.
Conclusions:
- Optimized pacifastin-derived peptides show significant promise for cancer imaging applications.
- Further development is needed to overcome obstacles for their therapeutic use.
- These peptides offer a valuable tool for enhancing tumor visualization in surgical settings.
Related Concept Videos
Peptide Bonds
Measurement: Derived Units
Higher Derivatives
Derivatives
Peptide Identification Using Tandem Mass Spectrometry
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...
Derivatives: Problem Solving

